Application Nr Approved Date Route Status External Links
NDA021205 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Trizivir Is Indicated In Combination With Other Antiretrovirals Or Alone For The Treatment Of Human Immunodeficiency Virus Type 1 (hiv‑1) Infection. Limitations Of Use: • Limited Data Exist On The Use Of Trizivir Alone In Patients With Higher Baseline Viral Load Levels (greater Than 100,000 Copies Per Ml) [see Clinical Studies ( 14 )] . Trizivir, A Combination Of Abacavir, Lamivudine, And Zidovudine, Each Nucleoside Analogue Hiv-1 Reverse Transcriptase Inhibitors, Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv‑1 Infection. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 3 Total)

Comments